TXMD – TherapeuticsMD, Inc.
Float Short %
0.55
Margin Of Safety %
-47
Put/Call OI Ratio
0.02
EPS Next Q Diff
EPS Last/This Y
EPS This/Next Y
Price
2.62
Target Price
5
Analyst Recom
3
Performance Q
113.93
Relative Volume
0.7
Beta
0.5
Ticker: TXMD
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-12-26 | TXMD | 1.74 | 0.05 | 0.00 | 898 |
| 2025-12-29 | TXMD | 1.68 | 0.04 | 0.00 | 1002 |
| 2025-12-30 | TXMD | 1.6412 | 0.04 | 999.99 | 1002 |
| 2025-12-31 | TXMD | 1.61 | 0.04 | 999.99 | 1002 |
| 2026-01-02 | TXMD | 1.63 | 0.04 | 50.00 | 1003 |
| 2026-01-05 | TXMD | 1.79 | 0.09 | 0.00 | 1054 |
| 2026-01-06 | TXMD | 2.09 | 0.09 | 0.00 | 1109 |
| 2026-01-07 | TXMD | 2.02 | 0.09 | 0.00 | 1109 |
| 2026-01-08 | TXMD | 2.08 | 0.09 | 0.00 | 1115 |
| 2026-01-09 | TXMD | 2.16 | 0.09 | 0.00 | 1115 |
| 2026-01-12 | TXMD | 2.09 | 0.09 | 0.33 | 1129 |
| 2026-01-13 | TXMD | 2.1 | 0.09 | 0.33 | 1129 |
| 2026-01-14 | TXMD | 2.12 | 0.09 | 0.00 | 1130 |
| 2026-01-15 | TXMD | 2.24 | 0.09 | 999.99 | 1135 |
| 2026-01-16 | TXMD | 2.23 | 0.10 | 0.00 | 1144 |
| 2026-01-20 | TXMD | 2.53 | 0.03 | 0.00 | 1047 |
| 2026-01-21 | TXMD | 2.52 | 0.03 | 0.00 | 1052 |
| 2026-01-22 | TXMD | 2.55 | 0.03 | 0.00 | 1072 |
| 2026-01-23 | TXMD | 2.62 | 0.02 | 0.00 | 1272 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-12-26 | TXMD | 1.70 | - | - | - |
| 2025-12-29 | TXMD | 1.68 | - | - | - |
| 2025-12-30 | TXMD | 1.63 | - | - | - |
| 2025-12-31 | TXMD | 1.62 | - | - | - |
| 2026-01-02 | TXMD | 1.64 | - | - | - |
| 2026-01-05 | TXMD | 1.80 | - | - | - |
| 2026-01-06 | TXMD | 2.07 | - | - | - |
| 2026-01-07 | TXMD | 2.02 | - | - | - |
| 2026-01-08 | TXMD | 2.09 | - | - | - |
| 2026-01-09 | TXMD | 2.12 | - | - | - |
| 2026-01-12 | TXMD | 2.09 | - | - | - |
| 2026-01-13 | TXMD | 2.09 | - | - | - |
| 2026-01-14 | TXMD | 2.10 | - | - | - |
| 2026-01-15 | TXMD | 2.23 | - | - | - |
| 2026-01-16 | TXMD | 2.25 | - | - | - |
| 2026-01-20 | TXMD | 2.53 | - | - | - |
| 2026-01-21 | TXMD | 2.54 | - | - | - |
| 2026-01-22 | TXMD | 2.57 | - | - | - |
| 2026-01-23 | TXMD | 2.62 | - | - | - |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-12-26 | TXMD | 0.00 | 0.46 | 0.59 |
| 2025-12-29 | TXMD | 0.00 | 0.46 | 0.59 |
| 2025-12-30 | TXMD | 4.91 | 0.46 | 0.59 |
| 2025-12-31 | TXMD | 4.91 | 0.46 | 0.59 |
| 2026-01-02 | TXMD | 4.91 | 0.46 | 0.59 |
| 2026-01-05 | TXMD | 4.91 | 0.47 | 0.59 |
| 2026-01-06 | TXMD | 4.69 | 0.47 | 0.59 |
| 2026-01-07 | TXMD | 4.69 | 0.47 | 0.59 |
| 2026-01-08 | TXMD | 4.69 | 0.47 | 0.59 |
| 2026-01-09 | TXMD | 4.69 | 0.47 | 0.59 |
| 2026-01-12 | TXMD | 4.93 | 0.47 | 0.59 |
| 2026-01-13 | TXMD | 4.69 | 0.47 | 0.55 |
| 2026-01-14 | TXMD | 4.69 | 0.47 | 0.55 |
| 2026-01-15 | TXMD | 4.69 | 0.47 | 0.55 |
| 2026-01-16 | TXMD | 4.69 | 0.47 | 0.55 |
| 2026-01-20 | TXMD | 4.69 | 0.47 | 0.55 |
| 2026-01-21 | TXMD | 4.69 | 0.47 | 0.55 |
| 2026-01-22 | TXMD | 4.69 | 0.47 | 0.55 |
| 2026-01-23 | TXMD | 4.69 | 0.47 | 0.55 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
Avg. EPS Est. Next Quarter
Insider Transactions
4.69
Institutional Transactions
0.47
Beta
0.5
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
1.39
Quality Score
37
Growth Score
41
Sentiment Score
94
Actual DrawDown %
98.1
Max Drawdown 5-Year %
-99.4
Target Price
5
P/E
100
Forward P/E
PEG
P/S
10.79
P/B
1.1
P/Free Cash Flow
14.6
EPS
0.03
Average EPS Est. Cur. Y
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
10.8
Relative Volume
0.7
Return on Equity vs Sector %
-26.2
Return on Equity vs Industry %
-6
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
TherapeuticsMD, Inc.Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 1
TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
stock quote shares TXMD – TherapeuticsMD, Inc. Stock Price stock today
news today TXMD – TherapeuticsMD, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch TXMD – TherapeuticsMD, Inc. yahoo finance google finance
stock history TXMD – TherapeuticsMD, Inc. invest stock market
stock prices TXMD premarket after hours
ticker TXMD fair value insiders trading